-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UUJMsHSvcLO+5w59UM3jWnwoy2Bf2tM7KLngw37eiUkeZTMKDjlLBvLkqUFZxTve gs7XdHx7rjBNTKj5nFgPrg== 0001088020-05-000017.txt : 20050331 0001088020-05-000017.hdr.sgml : 20050331 20050331172949 ACCESSION NUMBER: 0001088020-05-000017 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050303 FILED AS OF DATE: 20050331 DATE AS OF CHANGE: 20050331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eigner Frederic CENTRAL INDEX KEY: 0001322419 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 05722112 BUSINESS ADDRESS: BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2005-03-03 0 0000892160 DERMA SCIENCES, INC. DSCI 0001322419 Eigner Frederic 214 CARNEGIE CENTER SUITE 100 PRINCETON NJ 08540 0 1 0 0 Executive VP Operations stock option (right to buy) 0.57 2002-09-15 2012-09-15 common stock 50000 D stock option (right to buy) 1.7 2003-07-07 2013-07-07 common stock 20000 D stock option (right to buy) 1.55 2004-02-24 2014-02-24 common stock 30000 D stock option (right to buy) 0.5 2005-03-30 2015-03-30 common stock 150000 D The options vest as to 10,000 shares per year, starting on the grant date. The options vest as to 4,000 shares per year, starting on the grant date. The options vest as to 7,500 shares per year, starting on the grant date. Options for 37,500 shares vest as to 9,375 shares per year, starting on the grant date. The remaining 112,500 vest on performance at the discretion of the board of directors. Frederic Eigner by Raymond C. Hedger, Jr., Attorney In Fact 2005-03-31 EX-24 2 eigner_poa.txt EIGNER CONFIRMATION STATEMENT I, Frederic Eigner, hereby authorize and designate Hedger & Hedger, by Raymond C. Hedger, Jr. or Samantha J. Prince, to file on my behalf with the United States Securities and Exchange Commission Form 3-Initial Statement of Beneficial Ownership of Securities, Form 4-Statement of Changes in Beneficial Ownership, Form 5-Annual Statement of Changes in Beneficial Ownership, and Schedules 13D and 13G-Information Statements pursuant to Rules 13d-1 and 13d-2, during my tenure as an executive officer of Derma Sciences, Inc. Date: March 10, 2005 /s/Frederic Eigner ----------------------- Frederic Eigner -----END PRIVACY-ENHANCED MESSAGE-----